4th Annual Advances In Immuno-Oncology Congress 2019

20 – 21 May 2019, London, UK

 

Oxford Global is proud to present the 4^th Annual Advances In Immuno-Oncology Congress, taking place on 20^th – 21^st of May in London. The congress will bring together over 300 delegates from global pharmaceutical organisations, leading biotech companies & internationally renowned academic institutions working on the key developments in Immuno-Oncology from early discovery through to the clinic.

 

Over the 2 days, the comprehensive & interactive programme will cover topics such as:

♦ The Discovery of Immuno-Oncology Therapies

♦ Preclinical Development – Screening, Assays and Modelling in Immuno-Oncology

♦ Translational Immuno-Oncology

♦ Precision Medicine and Personalised Therapy

♦ Genomics in Cancer Immunotherapy

♦ Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials

 

View the full agenda: http://bit.ly/2OQ92RJ

 

Want to gain some valuable pre-congress insights? Take a look at some of our previous webinars:

 

♦ Personalised Medicine & Immuno-Oncology

Presented by Agnete Fredriksen | Chief Scientific Officer, Vaccibody    

 

♦ Novel Checkpoint Inhibitors & Strategies for Combines Modality Treatment

Presented by Geert Mudde | Founder & CSO of OncoQR ML GmbH

Christoph Goletz | Senior Scientist Immuno-Oncology, Glycotope GmbH

 

♦ Approaches to the Development of Novel Cancer Immunotherapies

Marlon Hinner | Director of Immuno-Oncology, Pieris Pharmaceuticals

 

♦ Immunotherapy of Bladder Cancer

Winald Gerritsen | Professor, Radboud University Medical Centre

 

Download the webinar recordings for free: http://bit.ly/2NytOAo

 

For more details:

Visit the congress website: http://bit.ly/2QeSO6h

Register your interest & book now: http://bit.ly/2G0N63d 

Or for further information, prices & group discounts please contact: marketing@oxfordglobal.co.uk